A novel approach for characterization of <scp>KSHV</scp>‐associated multicentric Castleman disease from effusions
Ting Zhou(Memorial Sloan Kettering Cancer Center), Hao‐Wei Wang(Fu Jen Catholic University), Kyle Moore(Frederick National Laboratory for Cancer Research), Kathryn Lurain(The Ohio State University), Armando Filie(National Institutes of Health), Mark Raffeld(National Cancer Institute), Linda M. Weaver(National Institutes of Health), Clarissa Rous(National Institutes of Health), Stefania Pittaluga(New York University), Denise Whitby(Frederick National Laboratory for Cancer Research), Thomas S. Uldrick(Regeneron (United States)), Vickie Marshall(Leidos (United States)), Maryalice Stetler‐Stevenson(National Cancer Institute), Ramya Ramaswami(National Cancer Institute), Elaine S. Jaffe(National Cancer Institute), Robert Yarchoan(National Cancer Institute), Constance M. Yuan(National Cancer Institute)
Cited by 19
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
|Blood|2011|2k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k